General Archive
-
News releasesTribune Therapeutics raises EUR 37 million for next-generation anti-fibrotic therapies
Tribune Therapeutics AB, a biotechnology company dedicated to treating the root causes of fibrotic diseases, today announced it has raised…
-
News releasesHillstar Bio closes $67 million Series A financing round
Hillstar Bio, a leading biotechnology company focused on developing next-generation precision immunology therapies for autoimmune diseases, today announced the successful…
-
News releasesLifeArc invests in Maxion Therapeutics Series A
Maxion Therapeutics (“Maxion”), a biotechnology company developing antibody-based KnotBody® drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases,…
-
ArticlesLifeArc Ventures 2024: new investments, targeted follow-ons and substantive portfolio progress
LifeArc Ventures, which invests in innovative early-stage life science companies as part of LifeArc, today announced substantial progress in 2024,…
-
ArticlesClare Terlouw, Head of LifeArc Ventures, talks to In Vivo’s Ashley Yeo on the improving investment climate
“There is a lot of capital out there in biotech land that has been largely locked up. Companies are coming…
-
News releasesLifeArc Ventures invests in Fluid Biomed
Fluid Biomed Inc., a clinical stage medical device company developing lifesaving products for patients suffering from vascular disease, closed an…
-
TechBio UK: Frontiers of Discovery
About the event TechBio UK: Frontiers of Discovery is an event for professionals at the intersection of biotechnology and technology. This…
-
News releasesLifeArc Ventures: Six new investments, portfolio progress and an expanding investment team
LifeArc Ventures, which is committed to investing in innovative early-stage life science companies, today provides an update on its portfolio.…
-
News releases
3 LifeArc Ventures’ portfolio companies celebrated in new report on most innovative life science businesses in UK
With the UK setting its sights on becoming a global life sciences superpower, it has created an environment where scientists…
-
News releases
LifeArc Ventures: Ozlo Sleep Emerges from Stealth and Unveils Flagship Product Ozlo Sleepbuds®
Ozlo Sleep (Ozlo), a science-driven sleep and audio technology company, emerged from stealth today with plans to launch Ozlo Sleepbuds®, a…
-
News releases
LifeArc Ventures launches new brand with dedicated website, LinkedIn and Twitter
Enabling LifeArc Ventures to speak directly to fellow investors, life science companies and entrepreneurial scientists.
-
News releasesLifeArc Ventures invests in Maxion Therapeutics
Investment in Maxion Therapeutics to drive antibody development for previously untreatable ion channel and GPCR-driven diseases